• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

趋化因子受体CXCR4作为神经外胚层肿瘤的治疗靶点

Chemokine receptor CXCR4 as a therapeutic target for neuroectodermal tumors.

作者信息

Shim Hyunsuk, Oishi Shinya, Fujii Nobutaka

机构信息

Department of Radiology, Emory University, Atlanta, GA 30322, USA.

出版信息

Semin Cancer Biol. 2009 Apr;19(2):123-34. doi: 10.1016/j.semcancer.2008.11.004. Epub 2008 Nov 25.

DOI:10.1016/j.semcancer.2008.11.004
PMID:19084067
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3091135/
Abstract

Chemokines (chemotactic cytokines) are a family of proteins associated with the trafficking and activation of leukocytes and other cell types in immune surveillance and inflammatory response. Besides their roles in the immune system, they play pleiotropic roles in tumor initiation, promotion, and progression. Chemokines can be classified into four subfamilies of chemokines, CXC, CC, C, or CX3C, based on their number and spacing of conserved cysteine residues near the N-terminus. This CXC subfamily can be further subclassified into two groups, depending on the presence or absence of a tripeptide motif glutamic acid-leucine-arginine (ELR) in the N-terminal domain. ELR(-)CXCL12, which binds to CXCR4 has been frequently implicated in various cancers. Over the past several years, studies have increasingly shown that the CXCR4/CXCL12 axis plays critical roles in tumor progression, such as invasion, angiogenesis, survival, homing to metastatic sites. This review focuses on involvement of CXCR4/CXCL12 interaction in neuroectodermal cancers and their therapeutic potentials. As an attractive therapeutic target of CXCR4/CXCL12 axis for cancer chemotherapy, development history and application of CXCR4 antagonists are described.

摘要

趋化因子(趋化性细胞因子)是一类蛋白质,在免疫监视和炎症反应中与白细胞及其他细胞类型的运输和激活相关。除了在免疫系统中的作用外,它们在肿瘤的起始、促进和进展过程中发挥着多效性作用。趋化因子可根据其N端附近保守半胱氨酸残基的数量和间距分为四个亚家族:CXC、CC、C或CX3C。根据N端结构域中是否存在三肽基序谷氨酸 - 亮氨酸 - 精氨酸(ELR),CXC亚家族可进一步细分为两组。与CXCR4结合的ELR( - )CXCL12常与多种癌症相关。在过去几年中,越来越多的研究表明,CXCR4/CXCL12轴在肿瘤进展中发挥关键作用,如侵袭、血管生成、存活、归巢至转移部位。本综述重点关注CXCR4/CXCL12相互作用在神经外胚层肿瘤中的作用及其治疗潜力。作为癌症化疗中CXCR4/CXCL12轴的一个有吸引力的治疗靶点,描述了CXCR4拮抗剂的开发历史和应用。

相似文献

1
Chemokine receptor CXCR4 as a therapeutic target for neuroectodermal tumors.趋化因子受体CXCR4作为神经外胚层肿瘤的治疗靶点
Semin Cancer Biol. 2009 Apr;19(2):123-34. doi: 10.1016/j.semcancer.2008.11.004. Epub 2008 Nov 25.
2
The role of CXC chemokines and their receptors in cancer.CXC趋化因子及其受体在癌症中的作用。
Cancer Lett. 2008 Aug 28;267(2):226-44. doi: 10.1016/j.canlet.2008.04.050. Epub 2008 Jun 24.
3
Oncogenic roles and drug target of CXCR4/CXCL12 axis in lung cancer and cancer stem cell.CXCR4/CXCL12轴在肺癌及癌症干细胞中的致癌作用与药物靶点
Tumour Biol. 2016 Jul;37(7):8515-28. doi: 10.1007/s13277-016-5016-z. Epub 2016 Apr 14.
4
Inhibitors of CXC chemokine receptor type 4: putative therapeutic approaches in inflammatory diseases.CXC 趋化因子受体 4 抑制剂:炎症性疾病的潜在治疗方法。
Curr Opin Hematol. 2014 Jan;21(1):29-36. doi: 10.1097/MOH.0000000000000002.
5
New cytokine: stromal derived factor-1.新型细胞因子:基质衍生因子-1。
Eur J Gynaecol Oncol. 2009;30(2):124-7.
6
The importance of the CXCL12-CXCR4 chemokine ligand-receptor interaction in prostate cancer metastasis.CXCL12-CXCR4趋化因子配体-受体相互作用在前列腺癌转移中的重要性。
J Exp Ther Oncol. 2004 Dec;4(4):291-303.
7
CXCL12-CXCR4/CXCR7 Axis in Colorectal Cancer: Therapeutic Target in Preclinical and Clinical Studies.CXCL12-CXCR4/CXCR7 轴在结直肠癌中的作用:临床前和临床研究中的治疗靶点。
Int J Mol Sci. 2021 Jul 9;22(14):7371. doi: 10.3390/ijms22147371.
8
CXCL12-CXCR4 axis in angiogenesis, metastasis and stem cell mobilization.CXCL12-CXCR4 轴在血管生成、转移和干细胞动员中的作用。
Curr Pharm Des. 2010;16(35):3903-20. doi: 10.2174/138161210794455003.
9
Synergy between coproduced CC and CXC chemokines in monocyte chemotaxis through receptor-mediated events.共同产生的CC趋化因子和CXC趋化因子通过受体介导的事件在单核细胞趋化中发挥协同作用。
Mol Pharmacol. 2008 Aug;74(2):485-95. doi: 10.1124/mol.108.045146. Epub 2008 May 9.
10
Chemokines in neuroectodermal cancers: the crucial growth signal from the soil.神经外胚层肿瘤中的趋化因子:来自“土壤”的关键生长信号
Semin Cancer Biol. 2009 Apr;19(2):103-10. doi: 10.1016/j.semcancer.2008.10.009. Epub 2008 Oct 28.

引用本文的文献

1
Metabolic Reprogramming Shapes the Progression and Therapeutic Landscape of Ovarian Cancer.代谢重编程塑造卵巢癌的进展和治疗格局。
Cancer Manag Res. 2025 Aug 19;17:1707-1722. doi: 10.2147/CMAR.S538281. eCollection 2025.
2
Research Progress of CXCR4-Targeting Radioligands for Oncologic Imaging.CXCR4 靶向放射性配体在肿瘤成像中的研究进展。
Korean J Radiol. 2023 Sep;24(9):871-889. doi: 10.3348/kjr.2023.0091.
3
Identification of novel biomarkers of prostate cancer through integrated analysis.通过综合分析鉴定前列腺癌的新型生物标志物。

本文引用的文献

1
Chemokines in neuroectodermal development and their potential implication in cancer stem cell-driven metastasis.趋化因子在神经外胚层发育中的作用及其在癌症干细胞驱动的转移中的潜在意义。
Semin Cancer Biol. 2009 Apr;19(2):68-75. doi: 10.1016/j.semcancer.2008.11.003. Epub 2008 Nov 25.
2
The roles of chemokine CXCL12 in embryonic and brain tumor angiogenesis.趋化因子CXCL12在胚胎及脑肿瘤血管生成中的作用。
Semin Cancer Biol. 2009 Apr;19(2):111-5. doi: 10.1016/j.semcancer.2008.11.001. Epub 2008 Nov 7.
3
The role of chemokines in cancer immune surveillance by the adaptive immune system.
Transl Androl Urol. 2021 Aug;10(8):3239-3254. doi: 10.21037/tau-21-401.
4
Anti-tumor activity of nanomicelles encapsulating CXCR4 peptide antagonist E5.包裹CXCR4肽拮抗剂E5的纳米胶束的抗肿瘤活性
PLoS One. 2017 Aug 9;12(8):e0182697. doi: 10.1371/journal.pone.0182697. eCollection 2017.
5
Genetic variants associated with colorectal brain metastases susceptibility and survival.与结直肠癌脑转移易感性和生存率相关的基因变异。
Pharmacogenomics J. 2017 Jan;17(1):29-35. doi: 10.1038/tpj.2015.86. Epub 2015 Dec 22.
6
Tumor talk: understanding the conversation between the tumor and its microenvironment.肿瘤对话:理解肿瘤与其微环境之间的相互作用
Cancer Cell Microenviron. 2015 Apr 26;2(2):e773. doi: 10.14800/ccm.773.
7
Current molecular imaging positron emitting radiotracers in oncology.当前肿瘤学中的分子成像正电子发射放射性示踪剂。
Nucl Med Mol Imaging. 2011 Mar;45(1):1-14. doi: 10.1007/s13139-011-0075-y. Epub 2011 Feb 1.
8
β-Arrestin1 and distinct CXCR4 structures are required for stromal derived factor-1 to downregulate CXCR4 cell-surface levels in neuroblastoma.β-arrestin1 和独特的 CXCR4 结构对于基质衍生因子-1 下调神经母细胞瘤中 CXCR4 的细胞表面水平是必需的。
Mol Pharmacol. 2014 Apr;85(4):542-52. doi: 10.1124/mol.113.089714. Epub 2014 Jan 22.
9
Discovery and computer aided potency optimization of a novel class of small molecule CXCR4 antagonists.发现并通过计算机辅助优化新型小分子 CXCR4 拮抗剂。
PLoS One. 2013 Oct 18;8(10):e78744. doi: 10.1371/journal.pone.0078744. eCollection 2013.
10
Development of a unique small molecule modulator of CXCR4.开发一种独特的 CXCR4 小分子调节剂。
PLoS One. 2012;7(4):e34038. doi: 10.1371/journal.pone.0034038. Epub 2012 Apr 2.
趋化因子在适应性免疫系统进行癌症免疫监视中的作用。
Semin Cancer Biol. 2009 Apr;19(2):76-83. doi: 10.1016/j.semcancer.2008.10.011. Epub 2008 Nov 7.
4
Melanoma and innate immunity--aActive inflammation or just erroneous attraction? Melanoma as the source of leukocyte-attracting chemokines.黑色素瘤与先天免疫——是活跃的炎症反应还是仅仅是错误的吸引?作为白细胞趋化因子来源的黑色素瘤。
Semin Cancer Biol. 2009 Apr;19(2):84-91. doi: 10.1016/j.semcancer.2008.10.012. Epub 2008 Nov 7.
5
Chemokines in neuroectodermal tumour progression and metastasis.趋化因子在神经外胚层肿瘤进展和转移中的作用
Semin Cancer Biol. 2009 Apr;19(2):97-102. doi: 10.1016/j.semcancer.2008.10.003. Epub 2008 Nov 1.
6
Chemokine signaling in cancer: one hump or two?癌症中的趋化因子信号传导:是单峰还是双峰?
Semin Cancer Biol. 2009 Apr;19(2):116-22. doi: 10.1016/j.semcancer.2008.10.001. Epub 2008 Oct 17.
7
Combining SDF-1/CXCR4 antagonism and chemotherapy in relapsed acute myeloid leukemia.在复发急性髓系白血病中联合使用SDF-1/CXCR4拮抗剂与化疗
Leukemia. 2009 Feb;23(2):393-6. doi: 10.1038/leu.2008.182. Epub 2008 Jul 10.
8
The role of CXC chemokines and their receptors in cancer.CXC趋化因子及其受体在癌症中的作用。
Cancer Lett. 2008 Aug 28;267(2):226-44. doi: 10.1016/j.canlet.2008.04.050. Epub 2008 Jun 24.
9
Identification of novel non-peptide CXCR4 antagonists by ligand-based design approach.基于配体设计方法鉴定新型非肽类CXCR4拮抗剂
Bioorg Med Chem Lett. 2008 Jul 15;18(14):4124-9. doi: 10.1016/j.bmcl.2008.05.092. Epub 2008 May 29.
10
Chemokines as therapeutic targets in renal cell carcinoma.趋化因子作为肾细胞癌的治疗靶点
Expert Rev Anticancer Ther. 2008 Jun;8(6):887-93. doi: 10.1586/14737140.8.6.887.